This inventor holds 1 USPTO granted patent. Top assignee: Aridis Pharmaceuticals. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: The Innovations of Michael Rodolf
Introduction
Michael Rodolf is an accomplished inventor based in Ittigen, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of antigenic polypeptides for medical applications. His work focuses on addressing bacterial infections through innovative compositions and treatments.
Latest Patents
Michael Rodolf holds one patent that provides antigenic polypeptides expressed during infections caused by pathogenic organisms. This invention includes compositions for treating, preventing, or detecting bacterial infections, with a particular emphasis on vaccine compositions utilizing these polypeptides. Additionally, the invention encompasses antibodies directed towards the antigenic polypeptides.
Career Highlights
Rodolf is currently associated with Aridis Pharmaceuticals, where he continues to advance his research and development efforts. His work has the potential to significantly impact the medical field by providing new solutions for bacterial infections.
Collaborations
Some of his notable coworkers include Simon Urwyler and Markus Haake, who contribute to the collaborative environment at Aridis Pharmaceuticals.
Conclusion
Michael Rodolf's innovative work in the field of biotechnology exemplifies the importance of research in combating bacterial infections. His contributions through patents and collaborations highlight the ongoing efforts to improve medical treatments and outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile